This is the authors' abstract. We don't add key points for this paper.
Mycoplasma pneumoniae (MP) infects tens of millions of children in an epidemic year, yet registers as a rounding error in the mortality metrics by which global health allocates resources. We audited this invisibility by triangulating three evidence streams: six national and multinational surveillance systems; a M. pneumoniae–specific secondary analysis of Global Burden of Disease (GBD) 2023 data; and GBD-derived counterfactual projections of the 2023 resurgence extrapolated from pre-pandemic epidemic cycles. Under non-pharmaceutical interventions (NPIs), MP disappeared more completely and for longer than influenza or RSV; it returned along a policy-timed interval gradient — 6–7 months after NPI relaxation in China, 21–22 months in Japan — exceeding the no-COVID counterfactual projection by 19.2%, breaching its upper prediction interval. Modeled MP mortality in children aged 0–19 years (26,382 deaths, 95% uncertainty interval (UI) 18,984–36,012; ninth of 26 modeled lower respiratory infection (LRI) etiologies) concentrated where measurement is absent: 81.6% of estimated deaths in sub-Saharan Africa and South Asia, while infections peak at school ages where death is rarest — an infection–mortality dissociation that no single instrument of global health accounting can see. Chronic sequelae compound the omission: bronchiolitis obliterans developed in 7.3% of the largest post-pneumonia follow-up cohort, converting a survivable infection into decades of disability invisible to mortality-weighted metrics. The 2023–2024 resurgence was not an anomaly but an audit finding — a structural failure of measurement, not of biology. We propose five corrections with named institutional owners: MP-specific sentinel surveillance, sequelae-weighted burden metrics, resistance-stewardship infrastructure, diagnostic adoption standards, and vaccine prioritization.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: